Medicine Innovates Medicine Innovates: Delivering innovations in medicine to the world for better health and prosperity
-
From fat/adipose to engineered bone organ
-
Activation of the Unfolded Protein Response Downregulates Cardiac Ion Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
-
Thermoresponsive double network cryogels from dendronized copolymers showing tunable encapsulation and release of proteins.
-
Porous scaffolds with mechanical-biological properties balance for bone tissue engineering
-
A Novel Biofunctional Cryogel Scaffold for Corneal Stromal Tissue Repair
-
Oxidative stress preconditioning of mouse perivascular myogenic progenitors selects a subpopulation of cells with a distinct survival advantage in vitro and in vivo
-
Targeted Ovarian Cancer Chemotherapy by EGFR-Specific Peptide-Decorated Polymersomal Doxorubicin
-
Resisting chemoresistance: regulation of cancer-related pathways to hinder mitochondrial FoxO3A pro-survival activity
-
A lipid against pancreatic cancer: Reprogramming the tumor stroma
-
Activation of PD-L1 by the Hippo pathway in cancer immune evasion
-
pH-responsive chitosan nanoparticles from a novel twin-chain anionic amphiphile for delivery of vancomycin
-
Surveillance nanotechnology for multi-organ cancer metastases
-
Biologically Assembled Conductive Nanomesh Enzyme Platform
-
Next generation bone cement with tailor-designed antibiotics release profiles and prolonged antibacterial activity
-
Synergism of Water Shock and a Biocompatible Block Copolymer Potentiates the Antibacterial Activity of Graphene Oxide
-
Development of localized surface plasmon resonance biosensors for the detection of Brettanomyces bruxellensis in wine
-
GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells
-
Molecular chaperones shape protein production costs
-
Bettering BCG vaccine: LipY, an important antigen to boost BCG vaccine to counter active and latent infections of M. tuberculosis
-
Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity
-
Tumor Necrosis Factor Receptor 2 A Promising Target for Neurodegenerative Diseases